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Biomarkers are used to determine whether 
patients are responding successfully to pharma-
cological tuberculosis (TB) treatment. Serum 
IgM antiphospholipid antibodies have been pro-
posed as biomarkers for monitoring TB therapy 
[Goodridge et  al. 2012; Wallis et  al. 2013]. We 
previously demonstrated that IgM anticardi-
olipin (anti-CL) antibody levels decrease after 
two months of treatment. The aim of our study 
was to determine the effect of temperature and 
storage conditions on the integrity of serum IgM 
anti-CL antibodies [Pierangeli and Harris, 
2008].
Serum samples were collected from 16 patients 
diagnosed with pulmonary TB from Colon City, 
Panama. TB diagnosis was achieved either by acid 
fast bacilli sputum smear or sputum culture. 
None of the patients had been previously diag-
nosed with TB. The average age of the patients 
was 34 years old (range 23–46), and 10 patients 
(62.5%) were men. Only one patient was coin-
fected with human immunodeficiency virus 
(HIV). Each of the 16 serum samples was divided 
into seven subsets: three subsets were stored for 1 
week on crushed ice, at −20°C or at −80°C 
respectively; three subsets were stored for 1 week 
at the same temperatures, but the samples were 
exposed to five freeze–thaw cycles (FTCs); and 
one subset was maintained at 4°C for 4 weeks 
[Nassta et  al. 2013]. The levels of serum IgM 
anti-CL antibodies were determined for each 
sample using a modification of a previously 
described in-house enzyme-linked immunosorb-
ent assay (ELISA) [Goodridge et  al. 2012]. 
Differences between the 4ºC sample subset and 
the other six subsets were determined by the 
Wilcoxon signed rank test and considered signifi-
cant for p values less than 0.05. A serial dilution of 
a whole human IgM fraction was analyzed using 
the in-house ELISA to prepare a standard curve. 
Each dilution was measured in triplicate. A linear 
regression was obtained for the six optical density 
values of each IgM dilution. The standard curve 
resulted in an R2 = 0.9908 (p < 0.0001).
We compared the serum IgM anti-CL antibody 
levels between the sample subsets stored at differ-
ent temperatures for 1 week. The serum IgM anti-
CL antibody levels in the sample subset stored for 
1 week on ice and at −20°C were not significantly 
different from those of the sample subset stored at 
4°C (p > 0.05). The sample subset stored for 1 
week on ice showed IgM anti-CL antibody levels 
that were nearly the same as the levels in the sam-
ple subset stored at 4°C. However, the sample 
subset stored for 1 week at −20°C showed a non-
significant 46% decrease in serum IgM anti-CL 
levels when compared with the sample subset 
maintained at 4°C. The sample subset stored at 
−80°C for 1 week displayed a significant 55% 
decrease in serum IgM anti-CL levels (p = 0.012) 
when compared with the sample subset main-
tained at 4°C (Figure 1).
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The FTC did not alter serum IgM anti-CL levels. 
The sample subset that underwent FTC over 1 
week at −20°C showed a nonsignificant, 36% 
decrease (p > 0.05) in IgM anti-CL antibody lev-
els when compared with the sample subset stored 
at 4°C. However, significant differences in serum 
IgM anti-CL antibody levels were observed 
between the sample subset stored at 4°C and the 
sample subset stored under FTC at −80°C (p = 
0.021). Similarly, the serum IgM anti-CL anti-
body levels of the sample subset stored at −80°C 
significantly decreased by 52% (p = 0.012) when 
compared with the sample subset stored at 4°C 
(Figure 1). We also evaluated storage for 4 weeks 
at 4°C versus −20°C. We found a nonsignificant 
decrease in serum IgM anti-CL in the sample 
subset stored at −20°C compared with the sample 
subset stored at 4°C (data not shown).
A previous study reported a similar effect of tem-
perature on IgM, IgG and IgA anti-CL [Brey 
et al. 1994]. The authors added known concentra-
tions of freeze-dried polyclonal human immuno-
globulins to serum samples from healthy donors. 
Although this study revealed a significant decrease 
in IgG but not in IgM or IgA anti-CL antibodies, 
the study procedure does not resemble actual 
sample handling for biomarker tests during TB 
therapy monitoring. In contrast, our study showed 
that samples from TB patients can be stored on 
crushed ice, at 4°C or −20°C or under FTC for 1 
week without serum IgM anti-CL undergoing 
significant degradation. Similarly, these samples 
can be stored at −20°C for a period of 4 weeks 
without significant degradation. We found that 
serum IgM anti-CL stored at −80°C, either at a 
constant temperature for 1 week or under FTC, 
experienced degradation, presumably by cryopre-
cipitation. Proteins precipitate out of solution 
when frozen plasma is thawed and refrozen at 
very low temperatures [O’Shaughnessy et  al. 
2004]. In our study, we observed a white precipi-
tate in samples that were stored at both −20°C 
and −80°C. A detailed study is warranted to 
determine the effect of ultra-low-temperature 
storage on IgM anti-CL and other biomarker pro-
teins across different TB patient care and therapy 
schemes. Such studies should evaluate total IgM, 
IgM anti-CL and IgM against purified protein 
derivative (PPD) before, during and after storing 
Figure 1. IgM anticardiolipin antibody levels under different storage conditions. A total of 16 serum samples 
from pulmonary tuberculosis patients were prepared and divided into 7 subsets. Three serum sample subsets 
were stored for 1 week on crushed ice, at −20°C or at −80°C, respectively. Similarly, three serum sample 
subsets were stored under freeze–thaw cycles (FTC) over 1 week on crushed ice, at −20°C or at −80°C. 
Another sample subset was stored at 4°C. IgM anticardiolipin levels were determined by enzyme-linked 
immunosorbent assay. Arrows indicate the standard error. The Wilcoxon signed rank test was used to compare 
levels between the sample subsets. Significant differences are indicated with the corresponding p values.
A Ng, C Weeks-Galindo et al.
http://tar.sagepub.com 95
serum samples from TB patients. This approach 
will clarify whether IgM antibodies should be 
measured immediately after obtaining serum 
samples. Similar evaluations of antibody biomark-
ers for monitoring treatment of other chronic 
infections and autoimmune diseases, such as the 
16/6 idiotype for systemic lupus erythematosus, 
are also recommended [Blank and Shoenfeld, 
2008]. For now, we recommend against using 
sample sets stored at ultra-low temperatures when 
investigating serum IgM anti-CL antibody bio-
marker-based tests in TB patients.
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